Back

Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis

Huang, Y.-F.; Huang, K.-L.

2025-07-01 genetic and genomic medicine
10.1101/2025.06.28.25330486 medRxiv
Show abstract

Gliomas, particularly aggressive glioblastoma (GBM), pose significant therapeutic challenges due to limited understanding of their single-cell drivers. Here, we integrate large glioma genetic data with brain multi-omics (bulk and single-cell) to identify causal genes and their cell-type-specific roles. We prioritize 11 high-confidence and 47 potential causal genes; 41 are novel associations. Analyses suggest most of these 58 genes are druggable, supported by CRISPR/RNAi screens showing essentiality/dependency for 53.7% novel candidates in glioma cell lines. Single-cell data identifies astrocytes and oligodendrocyte precursor cells (OPCs) as likely GBM cells-of-origin and reveals increased tumor microenvironment (TME) communication involving neurons. We uncover 14 cell-type-specific causal gene effects, including EGFR in astrocytes, CDKN2A in OPCs, and JAK1 in excitatory neurons. Notably, 85.7% effects occur in non-risk populations (glial and neural), highlighting complex interplays. This study provides critical cell-resolved insights into glioma susceptibility mechanisms and identifies potential therapeutic targets within complex intratumoral interactions, advancing targeted precision therapies.

Published in Journal of Translational Medicine · training set

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.